The purpose of this Study is to find out whether an investigational drug is safe and well
tolerated. MW189 is being studied as a possible short-term treatment for people with
different types of brain injury. MW189 has previously been given to healthy human volunteers
as a single dose, and there were no significant problems or bad effects in people who
received the Study drug. However, before it can be tested in people with brain injury, it is
important to test MW189 in healthy volunteers when given multiple doses.
Phase:
Phase 1
Details
Lead Sponsor:
Linda Van Eldik
Collaborators:
Alzheimer's Association Duke Clinical Research Institute